Medications associated with Leukemia

Ingredients whose current FDA labeling lists an association with leukemia, extracted from manufacturer submissions via NIH DailyMed.

Medications

Label-linked ingredients

4-Hydroxycyclophosphamide

Malignant Diseases Cyclophosphamide Injection is indicated for the treatment of adult patients with: • maligna...

Medication

Allopurinol

THIS IS NOT AN INNOCUOUS DRUG. IT IS NOT RECOMMENDED FOR THE TREATMENT OF ASYMPTOMATIC HYPERURICEMIA. Allopuri...

Medication

Asciminib

SCEMBLIX is indicated for the treatment of adult patients with: Newly diagnosed Philadelphia chromosome-positi...

Medication

Asparaginase

RYLAZE is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lympho...

Medication

Azacitidine

ONUREG is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first c...

Medication

Bosutinib

Bosutinib tablets are indicated for the treatment of: Adult patients  with chronic phase (CP) Philadelphia chr...

Medication

Busulfan

Busulfan injection is indicated for use in combination with cyclophosphamide as a conditioning regimen prior t...

Medication

Chlorambucil

LEUKERAN (chlorambucil) is indicated in the treatment of chronic lymphatic (lymphocytic) leukemia, malignant l...

Medication

Clofarabine

Clofarabine Injection is indicated for the treatment of pediatric patients 1 to 21 years old with relapsed or ...

Medication

Cyclophosphamide Anhydrous

Malignant Diseases Cyclophosphamide Injection is indicated for the treatment of adult and pediatric patients w...

Medication

Cytarabine

Cytarabine Injection in combination with other approved anti-cancer drugs is indicated for remission induction...

Medication

Dasatinib

SPRYCEL® (dasatinib) is indicated for the treatment of adults with newly diagnosed Philadelphia chromosome-pos...

Medication

Dasatinib Anhydrous

Dasatinib tablet is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome...

Medication

Daunorubicin

Daunorubicin hydrochloride injection in combination with other approved anticancer drugs is indicated for remi...

Medication

Decitabine

Decitabine for injection is indicated for treatment of adult patients with myelodysplastic syndromes (MDS) inc...

Medication

Doxorubicin

Cardiomyopathy: Myocardial damage, including acute left ventricular failure can occur with doxorubicin. The ri...

Medication

Duvelisib

COPIKTRA is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leuk...

Medication

Filgrastim

Cancer Patients Receiving Myelosuppressive Chemotherapy NEUPOGEN® is indicated to decrease the incidence of in...

Medication

Fludarabine

Fludarabine Phosphate for Injection is indicated for the treatment of adult patients with B-cell chronic lymph...

Medication

Glasdegib

DAURISMO is indicated, in combination with low-dose cytarabine, for the treatment of newly-diagnosed acute mye...

Medication

Hydroxyurea

Significant tumor response to hydroxyurea capsules USP has been demonstrated in melanoma, resistant chronic my...

Medication

Idarubicin

Idarubicin Hydrochloride injection, USP in combination with other approved antileukemic drugs is indicated for...

Medication

Idelalisib

Zydelig is indicated, in combination with rituximab, for the treatment of patients with relapsed chronic lymph...

Medication

Inotuzumab Ozogamicin

BESPONSA is indicated for the treatment of relapsed or refractory CD22-positive B-cell precursor acute lymphob...

Medication

Mercaptopurine Anhydrous

Mercaptopurine tablets are indicated for maintenance therapy of acute lymphatic (lymphocytic, lymphoblastic) l...

Medication

Mitoxantrone

Mitoxantrone injection, USP (concentrate) is indicated for reducing neurologic disability and/or the frequency...

Medication

Moxetumomab Pasudotox

LUMOXITI is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL...

Medication

Nelarabine

Nelarabine Injection is indicated for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell ...

Medication

Olutasidenib

Relapsed or Refractory Acute Myeloid Leukemia REZLIDHIA is indicated for the treatment of adult patients with ...

Medication

Pemivibart

The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the emergency ...

Medication

Related testing

Lab tests that investigate leukemia

Curious about testing? See the lab tests healthcare providers may use to investigate symptoms and conditions. Order online and visit a local collection site.
Explore lab testing options
FAQ

Frequently Asked Questions

What medications are used for leukemia?

The medications listed above are associated with leukemia in current FDA-approved labeling as reported by manufacturers through NIH DailyMed. Only a qualified prescriber can determine appropriate treatment.

Do these medications cure leukemia?

This site does not provide treatment advice. The list reflects labeled associations, not recommendations. Discuss options, risks, and benefits with your healthcare provider.

Medical disclaimer: Educational content only. Not medical advice or a treatment recommendation.

Educational content only: The information on Symptom Database.com is for educational purposes and is not medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Read our full disclaimer.